13F-HR filed by Tri Locum Partners LP
Tri Locum Partners LP filed this 13F-HR for the quarter ended 2021-09-30, filed 2021-11-15, with 28 holding rows worth $251,643,000.
- Accession
- 0001826434-21-000007
- Filer
- CIK 1826434
- Filed
- 2021-11-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2021
A holdings report, 30 entries on the cover page, a total value of $251,643,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $251,643,000 with VALUE read as thousands by filing date, 13F file number 028-21000. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 261,500 | $28,645,000 | thousands by filing date | |
| BAXTER INTL INC | 071813109 | COM | 312,400 | $25,126,000 | thousands by filing date | |
| WALGREENS BOOTS ALLIANCE INC | 931427108 | COM | 350,000 | $16,468,000 | thousands by filing date | call |
| SEAGEN INC | 81181C104 | COM | 96,307 | $16,353,000 | thousands by filing date | |
| WALGREENS BOOTS ALLIANCE INC | 931427108 | COM | 312,847 | $14,719,000 | thousands by filing date | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 122,880 | $13,911,000 | thousands by filing date | |
| Merck & Co.,Inc. | 58933Y105 | COM | 181,765 | $13,652,000 | thousands by filing date | |
| SKINHEALTH SYSTEMS INC | 88331L108 | COM CL A | 504,606 | $13,105,000 | thousands by filing date | |
| Medtronic Plc | G5960L103 | COM | 104,070 | $13,045,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 135,055 | $12,490,000 | thousands by filing date | |
| Merck & Co.,Inc. | 58933Y105 | COM | 150,500 | $11,304,000 | thousands by filing date | call |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 168,467 | $8,518,000 | thousands by filing date | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 13,950 | $8,442,000 | thousands by filing date | |
| LEAP THERAPEUTICS INC | 52187K101 | COM | 1,810,672 | $7,261,000 | thousands by filing date | |
| EAGLE PHARMACEUTICALS INC | 269796108 | COM | 122,503 | $6,833,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 377,708 | $6,134,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 32,851 | $6,064,000 | thousands by filing date | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 972,997 | $5,974,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 276,400 | $4,726,000 | thousands by filing date | call |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 264,134 | $4,036,000 | thousands by filing date | |
| NOVAVAX INC | 670002401 | COM NEW | 19,300 | $4,001,000 | thousands by filing date | call |
| CYCLACEL PHARMACE 6percent PFDCONV | 23254L603 | Stock | 522,943 | $2,756,000 | thousands by filing date | |
| LIFESCI ACQUISITION II CORP | 53229E103 | COM | 263,289 | $2,580,000 | thousands by filing date | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 5,506 | $1,503,000 | thousands by filing date | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 148,355 | $1,454,000 | thousands by filing date | |
| FEMASYS INC | 31447E105 | cs | 190,600 | $1,313,000 | thousands by filing date | |
| THERAVANCE BIOPHARMA INC | G8807B106 | COM | 129,192 | $956,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 16,045 | $274,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001826434-21-000007 | this filing | 2021-11-15 | acceptance time not in the bulk data set |